ACTIVE

Pharmacie de la Linière

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result57,6 k €+21,9 %over 1 year
Gross margin397,2 k €+12,0 %over 1 year
Equity363,6 k €+18,8 %over 1 year
Workforce3,0 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

Pharmacie de la Linière is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Perwez. It employs on average 3,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0846.065.375
Incorporation
14/05/2012
Legal form
Private limited company
Registered office
Rue de la Chapelle 35
1360 Perwez · WallonieSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2024
Average workforce
3,0 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 13 filings

Trend over 12 financial years

20242023202220212019
Income statement
Gross margin397,2 k €354,7 k €439 k €340 k €346,4 k €
EBITDA136,8 k €107,8 k €184,9 k €111,4 k €130,2 k €
Operating result102,7 k €74,6 k €145,5 k €63,5 k €84,6 k €
Net result57,6 k €47,3 k €98,4 k €38,1 k €53,4 k €
Balance sheet
Equity363,6 k €306 k €258,7 k €160,3 k €71,9 k €
Total assets835,9 k €1 M €875,8 k €765,2 k €715,7 k €
Cash207,9 k €75,2 k €174,7 k €133,3 k €69,7 k €
Debts472,4 k €704,7 k €617,1 k €604,9 k €643,7 k €
Other
Workforce3,0 ETP3,0 ETP3,2 ETP3,3 ETP3,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 4 ended

Active mandates

FINANCIA PHARMA

Director · 0832.300.679

Represented by ANCIA Pierre

Active

Ended mandates

FINANCIA PHARMA

Manager · since 14 mai 2012 · 0832.300.679

Represented by PIERRE ANCIA

Ended
FINANCIA PHARMA

Manager · since 14 mai 2012 · 0832.300.679

Represented by PIERRE ANCIA

Ended
FINANCIA PHARMA

Director · 0832.300.679

Represented by Ancia PIERRE

Ended
Pierre Ancia

Director

Ended

Other companies at this address

Rue de la Chapelle 35 1360 Perwez
CompanyCBE no.
FINANCIA PHARMA● Active
0832.300.679
LOUVIMAR● Active
0463.466.493
PHARMACIE DE LA CHAPELLE● Active
0453.011.081

Full financial information

Source · NBB
202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date29/08/202502/08/202401/09/202329/08/202217/09/202121/08/2020
General meeting25/06/202526/06/202430/08/202322/06/202223/06/202124/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 13 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202425/06/202529/08/2025FrenchPDF
Abridged model31/12/202326/06/202402/08/2024FrenchPDF
Abridged model31/12/202230/08/202301/09/2023FrenchPDF
Abridged model31/12/202122/06/202229/08/2022FrenchPDF
Abridged model31/12/202023/06/202117/09/2021FrenchPDF
Abridged model31/12/201924/06/202021/08/2020FrenchPDF
Abridged model31/12/201826/06/201920/08/2019FrenchPDF
Abridged model31/12/201727/06/201823/08/2018FrenchPDF
Abridged model31/12/201628/06/201703/08/2017FrenchPDF
Abridged model31/12/201529/06/201625/08/2016FrenchPDF
Abridged model31/12/201424/06/201506/08/2015FrenchPDF
Abridged model31/12/201325/06/201422/12/2014FrenchPDF
Abridged model31/12/201226/06/201330/08/2013FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 4 ended

Active mandates

FINANCIA PHARMA

Director · 0832.300.679

Represented by ANCIA Pierre

Active

Ended mandates

FINANCIA PHARMA

Manager · since 14 mai 2012 · 0832.300.679

Represented by PIERRE ANCIA

Ended
FINANCIA PHARMA

Manager · since 14 mai 2012 · 0832.300.679

Represented by PIERRE ANCIA

Ended
FINANCIA PHARMA

Director · 0832.300.679

Represented by Ancia PIERRE

Ended
Pierre Ancia

Director

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates09/02/2024
    MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
    PDF
  • Other08/06/2012
    DIVERS
    PDF
  • Other04/06/2012
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 202457,6 k €↑
  2. 2023
    Annual accounts 202347,3 k €↓
  3. 2022
    Annual accounts 202298,4 k €↑
  4. 2021
    Annual accounts 202138,1 k €↓
  5. 2019
    Annual accounts 201953,4 k €↑
  6. 2018
    Annual accounts 201812 k €↑
  7. 2017
    Annual accounts 2017-3,5 k €↓
  8. 2016
    Annual accounts 201615,2 k €↓
  9. 2015
    Annual accounts 201518,7 k €↓
  10. 2014
    Annual accounts 201422,7 k €↓
  11. 2013
    Annual accounts 201344,4 k €↑
  12. 2012
    Annual accounts 2012-85,6 k €
  13. 14/05/2012
    IncorporationPrivate limited company